Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1974 Sep 14;3(5932):662–664. doi: 10.1136/bmj.3.5932.662

Blood Muramidase Activity in Colorectal Cancer

E H Cooper, R Turner, L Steele, J C Goligher
PMCID: PMC1611642  PMID: 4154118

Abstract

The serum muramidase levels were measured in 128 patients with primary or metastatic colorectal cancer, 166 tumour-free patients after resection of a colorectal cancer, and 172 controls. Muramidase levels over 10 μg/ml were detected in 30%-39% of the tumour-bearing patients, in 8·2% of the tumour free, and in only 1·7% of the controls (normal level 6·68 ± 1·42 μg/ml). Long-term follow up indicated that raised levels may occur as a transient phenomenon in recurrent or metastatic disease. The likely relation of abnormal serum muramidase activity and stimulation of the reticuloendothelial system is discussed.

Full text

PDF
662

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barrett O., Jr Monocytosis in malignant disease. Ann Intern Med. 1970 Dec;73(6):991–992. doi: 10.7326/0003-4819-73-6-991. [DOI] [PubMed] [Google Scholar]
  2. Egan M. L., Lautenschleger J. T., Coligan J. E., Todd C. W. Radioimmune assay of carcinoembryonic antigen. Immunochemistry. 1972 Mar;9(3):289–299. doi: 10.1016/0019-2791(72)90093-6. [DOI] [PubMed] [Google Scholar]
  3. FOGELSON S. J., LOBSTEIN O. E. A statistical comparison of the blood lysozyme activity of normal adults and of patients with localized and generalized carcinomatosis. Am J Dig Dis. 1954 Nov;21(11):324–326. doi: 10.1007/BF02883951. [DOI] [PubMed] [Google Scholar]
  4. Fink M. E., Finch S. C. Serum muramidase and granulocyte turnover. Proc Soc Exp Biol Med. 1968 Feb;127(2):365–367. doi: 10.3181/00379727-127-32692. [DOI] [PubMed] [Google Scholar]
  5. Gordon S., Todd J., Cohn Z. A. In vitro synthesis and secretion of lysozyme by mononuclear phagocytes. J Exp Med. 1974 May 1;139(5):1228–1248. doi: 10.1084/jem.139.5.1228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hayslett J. P., Perillie P. E., Finch S. C. Urinary muramidase and renal disease. Correlation with renal histology and implication for the mechanism of enzymuria. N Engl J Med. 1968 Sep 5;279(10):506–512. doi: 10.1056/NEJM196809052791002. [DOI] [PubMed] [Google Scholar]
  7. Kovanyi G., Letnansky K. Urine and blood serum muramidase (lysozyme) in patients with urogenital tumors. Eur J Cancer. 1971 Feb;7(1):25–31. doi: 10.1016/0014-2964(71)90091-0. [DOI] [PubMed] [Google Scholar]
  8. Levi J. A., Macqueen A., Vincent P. C. Assessment of the value of lysozyme assay in neutropenia. Br J Haematol. 1973 Dec;25(6):757–770. doi: 10.1111/j.1365-2141.1973.tb01788.x. [DOI] [PubMed] [Google Scholar]
  9. Moldow R. E. Monocytosis in malignancy. Ann Intern Med. 1971 Mar;74(3):449–449. doi: 10.7326/0003-4819-74-3-449_2. [DOI] [PubMed] [Google Scholar]
  10. PERRI G. C., CAPPUCCINO J. G., FAULK M., MELLORS J., STOCK C. C. Variations of the content of lysozyme in normal rats and rats bearing Jensen sarcoma following surgery. Cancer Res. 1963 Mar;23:431–435. [PubMed] [Google Scholar]
  11. PROCKOP D. J., DAVIDSON W. D. A STUDY OF URINARY AND SERUM LYSOZYME IN PATIENTS WITH RENAL DISEASE. N Engl J Med. 1964 Feb 6;270:269–274. doi: 10.1056/NEJM196402062700602. [DOI] [PubMed] [Google Scholar]
  12. Pascual R. S., Gee J. B., Finch S. C. Usefulness of serum lysozyme measurement in diagnosis and evaluation of sarcoidosis. N Engl J Med. 1973 Nov 15;289(20):1074–1076. doi: 10.1056/NEJM197311152892007. [DOI] [PubMed] [Google Scholar]
  13. Perillie P. E., Finch S. C. Lysozyme in leukemia. Med Clin North Am. 1973 Mar;57(2):395–407. doi: 10.1016/s0025-7125(16)32288-x. [DOI] [PubMed] [Google Scholar]
  14. Perillie P. E., Khan K., Finch S. C. Serum lysozyme in pulmonary tuberculosis. Am J Med Sci. 1973 Apr;265(4):297–302. doi: 10.1097/00000441-197304000-00005. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES